User profiles for "author:Filipe Barcelos"

FILIPE MACHADO BARCELOS

Ortopedista pediátrico, Hospital Israelita Albert Einstein
Verified email at einstein.br
Cited by 26

Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b …

SJ Bowman, R Fox, T Dörner, X Mariette, A Papas… - The Lancet, 2022 - thelancet.com
Background Sjögren's syndrome is an autoimmune disease characterised by dry eyes and
mouth, systemic features, and reduced quality of life. There are no disease-modifying …

Association study of IL10 and IL23R–IL12RB2 in Iranian patients with Behçet's disease

JM Xavier, F Shahram, F Davatchi, A Rosa… - Arthritis & …, 2012 - Wiley Online Library
Objective Independent replication of the findings from genome‐wide association studies
(GWAS) remains the gold standard for results validation. Our aim was to test the association …

[HTML][HTML] Comparative effectiveness of tocilizumab and TNF inhibitors in rheumatoid arthritis patients: data from the Rheumatic Diseases Portuguese Register, Reuma …

VC Romão, MJ Santos, J Polido-Pereira… - BioMed research …, 2015 - hindawi.com
Objectives. To compare the effectiveness of TNF inhibitors (TNFi) and tocilizumab in
rheumatoid arthritis (RA) treatment, according to different response criteria. Methods. We …

[HTML][HTML] Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis

F Barcelos, C Martins, R Monteiro, J Cardigos… - Scientific reports, 2021 - nature.com
Sjögren's syndrome (SjS) is characterized by lymphocytic infiltration of exocrine glands, ie
autoimmune epithelitis. Lymphocytes are central in SjS pathogenesis, with B-cell …

Effects of gustatory stimulants of salivary secretion on salivary pH and flow in patients with Sjögren's syndrome: a randomized controlled trial

DN da Silva Marques, ADSP da Mata… - Journal of oral …, 2011 - Wiley Online Library
J Oral Pathol Med (2011) 40: 785–792 Objectives: To compare salivary pH changes and
stimulation efficacy of two different gustatory stimulants of salivary secretion (GSSS) in …

Tear meniscus and corneal sub-basal nerve plexus assessment in primary Sjögren syndrome and Sicca syndrome patients

J Cardigos, F Barcelos, H Carvalho, D Hipólito… - Cornea, 2019 - journals.lww.com
Purpose: To evaluate lower tear meniscus and corneal sub-basal nerve plexus in primary
Sjögren's syndrome (pSS) and Sicca syndrome patients. Methods: Cross-sectional study of …

Patient‐related outcomes in Sjögren syndrome treated with stimulants of salivary secretion: Randomized clinical trial

ADSP da Mata, JPAR Amaral, WM Thomson… - Oral …, 2020 - Wiley Online Library
Objectives To investigate the impact of gustatory stimulants of salivary secretion (GSSS) on
Sjögren's syndrome patients' self‐perception of xerostomia, oral health‐related quality of life …

Validation of oral health impact profile-14 and its association with hypossialia in a Sjögren's Syndrome Portuguese population.

J Amaral, C Sanches, D Marques… - Acta Reumatologica …, 2018 - search.ebscohost.com
The objective of this study was to perform the Portuguese transcultural adaptation of the
original Brazilian version of the Oral Health Impact Profile-14 (OHIP-14) while evaluating the …

[PDF][PDF] Portuguese recommendations for the use of methotrexate in rheumatic diseases–2016 update

AC Duarte, D Santos-Faria, MJ Gonçalves… - Acta reumatologica …, 2017 - comum.rcaap.pt
Results: Results presented in this article are mainly in accordance with previous guidelines,
with some new information regarding hepatitis B infection during MTX treatment, pulmonary …

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.

F Barcelos, I Abreu, JV Patto… - Acta reumatológica …, 2009 - search.ebscohost.com
Objectives: The purpose of this study was to evaluate the prevalence and clinical
significance of anti-cyclic citrullinated peptide antibodies (anti-CCP-Abs), IgM and IgA …